Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Treatment on HBeAg Positive or HBeAg Negative in Chronic Hepatitis B (HBV)

Expanded access is currently available for this treatment.
Verified August 2016 by Triệu, Nguyễn Thị, M.D.
Sponsor:
Information provided by (Responsible Party):
Triệu, Nguyễn Thị, M.D.
ClinicalTrials.gov Identifier:
NCT01198860
First received: September 4, 2010
Last updated: August 16, 2016
Last verified: August 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: Expanded access is currently available for this treatment.
  Study Completion Date: May 2015
  Primary Completion Date: May 2015 (Final data collection date for primary outcome measure)